The proposed Center for Medicare & Medicaid Services (CMS) demonstration project to test alternative payment models for Part B drugs would save about 1% of the total amount spent on Medicare Part B if it were implemented as proposed, the Congressional Budget Office (CBO) indicates in an analysis released Oct. 4.
In a draft rule issued in March, CMS proposed testing alternatives to the statutory payment formula of ASP+6%. As proposed, CMS would start by paying half of Part B providers at ASP+2.5% plus a flat fee of $16.80. A second phase of the demo would then apply value-based pricing as an alternative to the ASP-based formulas
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?